Market revenue in 2020 | USD 28.0 billion |
Market revenue in 2028 | USD 106.9 billion |
Growth rate | 18.2% (CAGR from 2020 to 2028) |
Largest segment | Detection kits |
Fastest growing segment | Detection Kits |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Detection kits was the largest segment with a revenue share of 22.86% in 2020. Horizon Databook has segmented the China biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Strong government support and various initiatives are factors that increase demand for biotechnology reagents & kits. Made in China 2025 is an overarching Chinese government strategy document that describes China’s strategy to become a powerhouses in various sectors, including biopharmaceuticals and other medical technologies.
Especially for biotechnology, the roadmap aims for licensing 3 to 5 innovative biotech drugs and their companion diagnostic reagents as well as commercialize 30 to 35 new drugs by 2025. The country has listed broad goals of achieving excellent innovative capacity, manufacturing volume, and international competitiveness in pharmaceutical industry by 2025.
A major plan to advance its biotechnology industry is making biotechnology parks. The country is focused on accelerating the biotechnology industry, including the wide-scale development of personalized medicine & innovative drugs, broad use of genomics, and making gene and cell banks.
Horizon Databook provides a detailed overview of country-level data and insights on the China biotechnology reagents & kits market , including forecasts for subscribers. This country databook contains high-level insights into China biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account